Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects

David C. Rubinsztein, Jonathan C. Cohen, G. Michael Berger, Deneys R. Van Der Westhuyzen, Gerhard A. Coetzee, Wieland Gevers

Research output: Contribution to journalArticle

117 Scopus citations

Abstract

The retinyl palmitate fat tolerance test was used to measure chylomicron remnant clearance in 10 normal subjects (apolipoprotein E [apo E] isotypes 3 or 4 only), 6 normolipidemic apo E2/2 homozygotes and 5 familial hypercholesterolemic homozygotes. Skin fibroblasts with fully upregulated LDL receptors from the latter subjects degraded rabbit 125I-βVLDL in vitro at rates ranging from < 10-48% of normal. Experiments in vivo revealed no significant differences between the normal and homozygous familial hypercholesterolemic (FHH) subjects in chylomicron remnant clearance assessed on the basis of 'areas under the curves' for retinyl palmitate levels present in postprandial serum, chylomicron remnants (Sf. < 1,000), or chylomicrons (Sf. > 1,000). Remnant clearance was greatly decreased at all times in the apo E2/2 homozygotes, indicative of an important degree of flux control exerted by a receptor-mediated step involving apo E as ligand. The absence of any excess remnant accumulation in FHH subjects with varying 'impairment' of LDL receptor-mediated degradation of apo E-containing lipoproteins, permits the conclusion that chylomicron remnants are initially cleared from the plasma by apo E-recognizing receptors which are genetically distinct from LDL receptors.

Original languageEnglish (US)
Pages (from-to)1306-1312
Number of pages7
JournalJournal of Clinical Investigation
Volume86
Issue number4
DOIs
StatePublished - Jan 1 1990

    Fingerprint

Keywords

  • LDL receptor
  • apolipoprotein B
  • apolipoprotein E
  • chylomicron remnant
  • familial hypercholesterolemia
  • retinyl palmitate
  • vitamin A

ASJC Scopus subject areas

  • Medicine(all)

Cite this